Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405899 · ClinicalTrials.gov registry record
Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
A clinical trial, sponsored by West Penn Allegheny Health System.
- Completed
- Registry status
- 20
- Enrollment target
NCT00405899 is a clinical trial that has completed, run by West Penn Allegheny Health System. The registered enrollment target is 20 participants.
The verdict
NCT00405899 has completed, sponsored by West Penn Allegheny Health System.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether there is a relationship between interferon-gamma levels and the incidence of viral respiratory infections in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care (nasal steroids, antihistamines) over a 1-year period. The hypotheses to be tested are 1) interferon-gamma levels will be significantly increased 3, 6, 9 and 12 months in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care, 2) the incidence of viral respiratory infections will be reduced at 3, 6, 9 and 12 months in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00405899
The ClinicalTrials.gov registry entry for NCT00405899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Penn Allegheny Health System, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00405899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00405899 about?
NCT00405899 is a clinical study titled "Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections". The objective of this study is to determine whether there is a relationship between interferon-gamma levels and the incidence of viral respiratory infections in allergic children treated with allergy immunotherapy as compared to those treated with standard medical care (nasal steroids, antihistamine...
What is the current status of trial NCT00405899?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2006-10. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00405899?
This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.